Trials Sponsors Conditions Drugs Pricing

Conditions

Saphenous Vein Injury

Outcome Measures

Primary Outcomes (1)

Venous Treatment Satisfaction Questionnaire early score
Evaluate the post-operative patient satisfaction on the treatment of saphenous veins and varicose veins outside the operating theater under strict local anesthesia with a 1940 nm laser via the Venous Treatment Satisfaction Questionnaire early. Scale from 0 to 6 (a high score indicates a positive result).
12 days

Study Arms (1)

Primary or recurrent saphenous vein

Patients receiving routine care for endovenous laser ablation of the primary or recurrent saphenous vein (great saphenous vein, small saphenous vein or anterior saphenous vein)

Procedure: Endovenous laser ablation of the primary or recurrent saphenous vein

Interventions

Endovenous laser ablation of the primary or recurrent saphenous veinProcedure

Treatment of saphenous veins and varicose veins performed outside the operating room strictly under local anesthesia with a 1940 nm laser.

Primary or recurrent saphenous vein

Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.

Eligibility Criteria

Age18 Years+

Sexall

Healthy VolunteersNo

Age GroupsAdult (18-64), Older Adult (65+)

Sampling MethodNon-Probability Sample

Study Population

The study population will be composed of adult patients receiving routine care for Endovenous Laser Ablation of primary or recurrent saphenous vein (great saphenous vein, small saphenous vein or anterior saphenous vein) outside the operating theater under strict local anesthesia.

You may qualify if:

Age ≥ 18 years.

Sponsors & Collaborators

Euraxi Pharma
Industrycollaborator
GCS Ramsay Santé pour l'Enseignement et la Recherche
Otherlead

Study Sites (2)

Institut de Pathologie Vasculaire - Hôpital Privé Geoffroy Saint-Hilaire

Paris, 75005, France

RECRUITING

Claudine HAMEL-DESNOS, MDCONTACTclaudine.hamel-desnos@wanadoo.fr

Clinique de la Muette

Paris, 75116, France

RECRUITING

Anne-Sophie LENSEL, MDCONTACT

Central Study Contacts

Claudine HAMEL-DESNOS, MD

CONTACT

144085838 claudine.hamel-desnos@wanadoo.fr

Study Design

Study Type: observational
Observational Model: COHORT
Time Perspective: PROSPECTIVE
Target Duration: 1 Year
Sponsor Type: OTHER
Responsible Party: SPONSOR

Study Record Dates

First Submitted

June 1, 2026

First Posted

June 5, 2026

Study Start

October 1, 2026

Actual (reported)

Primary Completion

June 2028

Estimated

Planned date reported by the registry; this milestone is not confirmed as achieved.

Patient Satisfaction, Safety, and Efficacy of Endovenous Laser Treatment for Saphenous Veins and Varicose Veins

Brief Summary

Registry Overview

Trial Relationships

Study Timeline

First Submitted

First Posted

Study Start

Primary Completion

Study Completion

Conditions

Outcome Measures

Primary Outcomes (1)

Study Arms (1)

Primary or recurrent saphenous vein

Interventions

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (2)

Central Study Contacts

Study Design

Study Record Dates

You may not qualify if:

Source record

Locations

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

First Submitted

First Posted

Study Start

Primary Completion

Study Completion

Conditions

Outcome Measures

Primary Outcomes (1)

Study Arms (1)

Primary or recurrent saphenous vein

Interventions

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (2)

Central Study Contacts

Study Design

Study Record Dates

You may not qualify if:

Source record

Locations